Urologic Debate Part 1: Mri Vs. Molecular Markers: Which One Should I Use

Urologic Debate Part 1: MRI vs. Molecular Markers: Which One Should I Use? MRI Perspective

Grand Rounds in Urology

Urologic Debate Part 2: MRI vs. Molecular Markers: Which One Should I Use? Markers Perspective

Grand Rounds in Urology

Integrating MRI and Molecular Markers to Detect Aggressive Prostate Cancer

Grand Rounds in Urology

Forward Progress in Molecular Markers for Prostate Cancer

Grand Rounds in Urology

Genetics and Genomic Biomarkers: How Molecular Markers and mpMRI Play a Role

Grand Rounds in Urology

Next Generation Biomarkers: As Reflex, Combination, or First Line?

Grand Rounds in Urology

(12) Debate Pro Vs. Con: The Value of MR-Guided Biopsy

Targeted Prostate Biopsy

Daily Debate: Imaging in Urology

European Association of Urology

To the Point: Focal or Definitive Therapy for Prostate Cancer: MRI vs. Mapping Part I

Grand Rounds in Urology

PSMA Conundrums & Triplet vs Doublet | PROSPECT Podcast part 1

Liquid Biomarkers and MRI in Prostate Cancer – Complementary?

Grand Rounds in Urology

Urological Malignancies (case-based discussion, theory and questions)

MRI First: The Role of MRI in Biopsy Naïve Patients

Grand Rounds in Urology

Biomarkers: PSA, 4K, or PHI?

Grand Rounds in Urology

Molecular Markers in Neurosurgical Oncology - Prof. Dr. med. Joerg-Christian Tonn

Walter E. Dandy Neurosurgical Club, Romania

Updates in Prostate Cancer Biomarkers

Grand Rounds in Urology

Abandoned MRI turned on 😳😳😳

decayingmidwest

Peter C. Black, MD, FACS, FRCSC, on the usefulness of molecular markers in bladder cancer treatment

MRI-invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates

Grand Rounds in Urology

Panel Discussion Localized Disease Part 1

Grand Rounds in Urology